# Bortezomib in Patients With Chronic Graft Versus Host Disease

> **NCT01672229** · PHASE1 · COMPLETED · sponsor: **Mehrdad Abedi, MD** · enrollment: 16 (actual)

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **DRUG:** Bortezomib

## Key facts

- **NCT ID:** NCT01672229
- **Lead sponsor:** Mehrdad Abedi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2018-04-09
- **Final completion:** 2018-04-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672229, "Bortezomib in Patients With Chronic Graft Versus Host Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01672229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*